S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

COGT Cogent Biosciences Inc

7.71

0.42 (5.76%)

04 May 2024 - Closed

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Cogent Biosciences Charts.

Cogent Biosciences (NASDAQ:COGT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Cogent Biosciences Charts.

Cogent Biosciences Inc News

Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
Tuesday 9 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.

Cogent Biosciences Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
Friday 23 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
Wednesday 14 February 2024 (3 months ago) • GlobeNewswire Inc.

More Cogent Biosciences Inc News Articles

AUD vs US Dollar

Sterling vs AUD

Verizon Communications

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions